Literature DB >> 25037454

The combined loss of Gads and CD127 reveals a novel function of Gads prior to TCRβ expression.

Juan Xiong1, Brooks L Parker, Thomas M Yankee.   

Abstract

The Gads adaptor protein is an essential component of the T cell signaling complex critical for T cell receptor-mediated calcium mobilization. After expression of TCRβ in T cell precursors, Gads is required for optimal Bcl-2 expression and cell survival. Similarly, the IL-7 receptor chain CD127 is also necessary for optimal Bcl-2 expression and cell survival in TCRβ-expressing thymocytes. Based on these observations, we tested whether Gads and CD127 might regulate convergent or linear signaling pathways by crossing Gads(-/-) mice with CD127(-/-) mice. Thymi from Gads(-/-)CD127(-/-) mice were barely detectable and many of the thymocytes were within the DN1 population. By contrast, B cell development in the Gads(-/-)CD127(-/-) mice was comparable to that of CD127(-/-) mice, indicating that the combined loss of Gads and CD127 did not lead to a global deficit in hematopoiesis. Analysis of Lin(-)Sca-1(+)c-kit(+) bone marrow cells and bone marrow chimera experiments indicated that Gads(-/-)CD127(-/-) T cell precursors either failed to migrate into the thymus or survive in the thymus. These data demonstrate that Gads functions at a stage of T cell development that had not been previously described.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25037454      PMCID: PMC4162766          DOI: 10.1007/s12026-014-8556-6

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  47 in total

1.  Requirement for the SLP-76 adaptor GADS in T cell development.

Authors:  J Yoder; C Pham; Y M Iizuka; O Kanagawa; S K Liu; J McGlade; A M Cheng
Journal:  Science       Date:  2001-03-09       Impact factor: 47.728

2.  Subversion of the T/B lineage decision in the thymus by lunatic fringe-mediated inhibition of Notch-1.

Authors:  U Koch; T A Lacombe; D Holland; J L Bowman; B L Cohen; S E Egan; C J Guidos
Journal:  Immunity       Date:  2001-08       Impact factor: 31.745

3.  Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1.

Authors:  David J Izon; Jon C Aster; Yiping He; Andrew Weng; Fredrick G Karnell; Vytas Patriub; Lanwei Xu; Sonia Bakkour; Carlos Rodriguez; David Allman; Warren S Pear
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

4.  Suppression of thymic development by the dominant-negative form of Gads.

Authors:  K Kikuchi; Y Kawasaki; N Ishii; Y Sasaki; H Asao; T Takeshita; I Miyoshi; N Kasai; K Sugamura
Journal:  Int Immunol       Date:  2001-06       Impact factor: 4.823

5.  Gads-/- mice reveal functionally distinct subsets of TCRbeta+ CD4-CD8- double-negative thymocytes.

Authors:  Ling Zeng; Stacy L Dalheimer; Thomas M Yankee
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

Review 6.  LAT, the linker for activation of T cells: a bridge between T cell-specific and general signaling pathways.

Authors:  R L Wange
Journal:  Sci STKE       Date:  2000-12-19

7.  Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes.

Authors:  Anita Wolfer; Anne Wilson; Mohamed Nemir; H Robson MacDonald; Freddy Radtke
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

Review 8.  Regulation of thymocyte differentiation: pre-TCR signals and beta-selection.

Authors:  Alison M Michie; Juan Carlos Zúñiga-Pflücker
Journal:  Semin Immunol       Date:  2002-10       Impact factor: 11.130

9.  Interleukin-7 supports survival of T-cell receptor-β-expressing CD4(-) CD8(-) double-negative thymocytes.

Authors:  Juan Xiong; Brooks L Parker; Stacy L Dalheimer; Thomas M Yankee
Journal:  Immunology       Date:  2013-04       Impact factor: 7.397

10.  Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus.

Authors:  A Wilson; H R MacDonald; F Radtke
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.